White House: Sequestration Would Delay Drug Approval; Compromise FDA User Fee Goals, Food Safety-insidehealthpolicy: The White House Friday (Feb. 8) said sequestration would delay drug approvals, slash food safety inspections and hinder recently negotiated drug and device user fee goals if the across-the-board cuts are not averted. FDA is exploring cost-containment solutions such as using remote work plans, evaluating contracts to reduce duplication and leveraging expertise through various consortia, FDA Commissioner Margaret Hamburg told agency funding advocates this week. The strategies emerge in a tight fiscal climate that includes a continued standoff between President Barack Obama and Congress over the looming threat of sequestration set to take effect in less than a month.
Monday, February 11, 2013
White House: Sequestration Would Delay Drug Approval; Compromise FDA User Fee Goals, Food Safety
White House: Sequestration Would Delay Drug Approval; Compromise FDA User Fee Goals, Food Safety-insidehealthpolicy: The White House Friday (Feb. 8) said sequestration would delay drug approvals, slash food safety inspections and hinder recently negotiated drug and device user fee goals if the across-the-board cuts are not averted. FDA is exploring cost-containment solutions such as using remote work plans, evaluating contracts to reduce duplication and leveraging expertise through various consortia, FDA Commissioner Margaret Hamburg told agency funding advocates this week. The strategies emerge in a tight fiscal climate that includes a continued standoff between President Barack Obama and Congress over the looming threat of sequestration set to take effect in less than a month.
